4/17
08:41 am
optn
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, OPTN, AZEK, MESA on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, OPTN, AZEK, MESA on Behalf of Shareholders
4/7
01:04 pm
optn
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
4/4
07:00 pm
optn
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF
Neutral
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF
3/26
07:00 am
optn
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
Low
Report
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
3/22
07:54 am
optn
OptiNose, Inc. (NASDAQ: OPTN) was downgraded by analysts at Piper Sandler from a "strong-buy" rating to a "hold" rating.
Low
Report
OptiNose, Inc. (NASDAQ: OPTN) was downgraded by analysts at Piper Sandler from a "strong-buy" rating to a "hold" rating.
3/21
04:34 pm
optn
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
Low
Report
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
3/21
11:31 am
optn
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $9.00 price target on the stock, down previously from $15.00.
Low
Report
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $9.00 price target on the stock, down previously from $15.00.
3/21
09:40 am
optn
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders
3/21
08:09 am
optn
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock, down previously from $18.00.
Low
Report
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock, down previously from $18.00.
3/20
04:00 pm
optn
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of OptiNose, Inc. - OPTN
Neutral
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of OptiNose, Inc. - OPTN
3/20
10:05 am
optn
OPTN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of OptiNose, to Paratek Pharmaceuticals
Low
Report
OPTN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of OptiNose, to Paratek Pharmaceuticals
3/20
09:48 am
optn
OPTN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Optinose, Inc. Is Fair to Shareholders
Low
Report
OPTN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Optinose, Inc. Is Fair to Shareholders
3/20
09:00 am
optn
OptiNose, Inc. (NASDAQ: OPTN) was downgraded by analysts at Lake Street Capital from a "buy" rating to a "hold" rating.
Medium
Report
OptiNose, Inc. (NASDAQ: OPTN) was downgraded by analysts at Lake Street Capital from a "buy" rating to a "hold" rating.
3/20
08:28 am
optn
Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders
Low
Report
Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders
3/19
09:45 pm
optn
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call
High
Report
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call
3/11
04:15 pm
optn
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
Low
Report
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results